Gremlin Antibody from R&D Systems, a Bio-Techne Brand

Yes, the Gremlin antibody has been utilized in studies involving mouse models, such as in the research by Koli et al. (2016), where it was used to investigate the role of Gremlin-1 in idiopathic pulmonary fibrosis. The antibody was employed in immunohistochemistry to detect Gremlin-1 expression in lung tissues, demonstrating its relevance in studying lung fibrosis mechanisms.

The Gremlin antibody has been shown to work effectively in Western blot applications, as evidenced by its use in the study by Ichinose et al. (2021). In this study, the antibody was used at a dilution of 1:1000 to detect Gremlin-1 in cell lysates, confirming its suitability for this application.

Gremlin-1 has been implicated in the development of cortical excitatory neurons, as highlighted in the study by Ichinose et al. (2021). The research demonstrated that Gremlin-1 expression marks specific neuronal populations in the embryonic mouse brain and is crucial for the structural and functional maturation of the cortex.

Yes, targeting Gremlin-1 has therapeutic implications in chronic inflammatory conditions. For instance, Yang et al. (2021) found that blocking Gremlin-1 could prevent the progression of intestinal fibrosis by inhibiting fibroblast activation and fatty acid oxidation, suggesting a potential strategy for treating fibrosis-related diseases.